mevastatin has been researched along with cholecalciferol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujii, T; Fujii, Y; Ito, M; Machida, K; Ochiai, A | 1 |
| Hayashi, K; Ikushiro, S; Kamakura, M; Ohta, M; Sakaki, T; Shiro, Y; Sugimoto, H; Takita, T; Yasuda, K; Yasukawa, K | 1 |
1 review(s) available for mevastatin and cholecalciferol
| Article | Year |
|---|---|
Protein engineering of CYP105s for their industrial uses.
Topics: Actinobacteria; Amino Acid Substitution; Bacterial Proteins; Cholecalciferol; Conserved Sequence; Cytochrome P-450 Enzyme System; Ferredoxins; Gene Expression; Hydroxylation; Isoenzymes; Lovastatin; Molecular Docking Simulation; Mutation; Pravastatin; Protein Engineering; Streptomyces; Substrate Specificity | 2018 |
1 other study(ies) available for mevastatin and cholecalciferol
| Article | Year |
|---|---|
Efficient biotransformations using Escherichia coli with tolC acrAB mutations expressing cytochrome P450 genes.
Topics: Bacterial Outer Membrane Proteins; Calcifediol; Cholecalciferol; Cholestenones; Cytochrome P-450 Enzyme System; Escherichia coli; Escherichia coli Proteins; Hydrophobic and Hydrophilic Interactions; Intracellular Space; Lovastatin; Membrane Transport Proteins; Mutation; Oxidation-Reduction; Pravastatin; Spectrum Analysis; Stereoisomerism; Substrate Specificity | 2009 |